MorphoSys AG logo

MorphoSys AG Investor Relations Material

MorphoSys AG is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases. It offers MOR101 for the treatment of acute lymphoblastic leukemia. The company was founded in 1992 and is headquartered in Planegg, Germany

Upcoming events for

Q3 20222022-11-17
Q2 20222022-08-04

Latest company events

Ticker symbol

MOR

Country

Germany

Investor Relations Page

https://www.morphosys.com/ir

Dig deeper into the MorphoSys AG fundamentals on Quartr.

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
App store link
Android play link
Quartr app screenshot